| pubmed-article:19589538 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19589538 | lifeskim:mentions | umls-concept:C0034693 | lld:lifeskim |
| pubmed-article:19589538 | lifeskim:mentions | umls-concept:C0403592 | lld:lifeskim |
| pubmed-article:19589538 | lifeskim:mentions | umls-concept:C1527144 | lld:lifeskim |
| pubmed-article:19589538 | lifeskim:mentions | umls-concept:C0667301 | lld:lifeskim |
| pubmed-article:19589538 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:19589538 | pubmed:dateCreated | 2009-10-19 | lld:pubmed |
| pubmed-article:19589538 | pubmed:abstractText | Chronic allograft nephropathy (CAN) is a major cause of late allograft loss. Recent evidences suggest that Rho and its downstream effector ROCK may be greatly involved in the progression of renal fibrosis. Inhibition of Rho/ROCK pathway might interact with the inflammatory process in the renal interstitium, and antagonize the process of epithelial-to-mesenchymal transition (EMT). We hypothesized that Y-27632 could inhibit the chronic inflammatory process and prevent the progression of CAN. | lld:pubmed |
| pubmed-article:19589538 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19589538 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19589538 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19589538 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19589538 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19589538 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19589538 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19589538 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19589538 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19589538 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19589538 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19589538 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19589538 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19589538 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19589538 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19589538 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:19589538 | pubmed:issn | 1095-8673 | lld:pubmed |
| pubmed-article:19589538 | pubmed:author | pubmed-author:KouMM | lld:pubmed |
| pubmed-article:19589538 | pubmed:author | pubmed-author:ZhangWeiW | lld:pubmed |
| pubmed-article:19589538 | pubmed:author | pubmed-author:LiuMinM | lld:pubmed |
| pubmed-article:19589538 | pubmed:author | pubmed-author:ZhuPengchengP | lld:pubmed |
| pubmed-article:19589538 | pubmed:author | pubmed-author:WuYichaoY | lld:pubmed |
| pubmed-article:19589538 | pubmed:author | pubmed-author:YinChangjunC | lld:pubmed |
| pubmed-article:19589538 | pubmed:author | pubmed-author:ZhangWei JWJ | lld:pubmed |
| pubmed-article:19589538 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19589538 | pubmed:volume | 157 | lld:pubmed |
| pubmed-article:19589538 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19589538 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19589538 | pubmed:pagination | e117-27 | lld:pubmed |
| pubmed-article:19589538 | pubmed:meshHeading | pubmed-meshheading:19589538... | lld:pubmed |
| pubmed-article:19589538 | pubmed:meshHeading | pubmed-meshheading:19589538... | lld:pubmed |
| pubmed-article:19589538 | pubmed:meshHeading | pubmed-meshheading:19589538... | lld:pubmed |
| pubmed-article:19589538 | pubmed:meshHeading | pubmed-meshheading:19589538... | lld:pubmed |
| pubmed-article:19589538 | pubmed:meshHeading | pubmed-meshheading:19589538... | lld:pubmed |
| pubmed-article:19589538 | pubmed:meshHeading | pubmed-meshheading:19589538... | lld:pubmed |
| pubmed-article:19589538 | pubmed:meshHeading | pubmed-meshheading:19589538... | lld:pubmed |
| pubmed-article:19589538 | pubmed:meshHeading | pubmed-meshheading:19589538... | lld:pubmed |
| pubmed-article:19589538 | pubmed:meshHeading | pubmed-meshheading:19589538... | lld:pubmed |
| pubmed-article:19589538 | pubmed:meshHeading | pubmed-meshheading:19589538... | lld:pubmed |
| pubmed-article:19589538 | pubmed:meshHeading | pubmed-meshheading:19589538... | lld:pubmed |
| pubmed-article:19589538 | pubmed:meshHeading | pubmed-meshheading:19589538... | lld:pubmed |
| pubmed-article:19589538 | pubmed:meshHeading | pubmed-meshheading:19589538... | lld:pubmed |
| pubmed-article:19589538 | pubmed:meshHeading | pubmed-meshheading:19589538... | lld:pubmed |
| pubmed-article:19589538 | pubmed:meshHeading | pubmed-meshheading:19589538... | lld:pubmed |
| pubmed-article:19589538 | pubmed:meshHeading | pubmed-meshheading:19589538... | lld:pubmed |
| pubmed-article:19589538 | pubmed:meshHeading | pubmed-meshheading:19589538... | lld:pubmed |
| pubmed-article:19589538 | pubmed:meshHeading | pubmed-meshheading:19589538... | lld:pubmed |
| pubmed-article:19589538 | pubmed:meshHeading | pubmed-meshheading:19589538... | lld:pubmed |
| pubmed-article:19589538 | pubmed:meshHeading | pubmed-meshheading:19589538... | lld:pubmed |
| pubmed-article:19589538 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19589538 | pubmed:articleTitle | Therapeutic effect of Y-27632 on chronic allograft nephropathy in rats. | lld:pubmed |
| pubmed-article:19589538 | pubmed:affiliation | Nanjing Medical University First Affiliated Hospital, Jiangsu, China. | lld:pubmed |
| pubmed-article:19589538 | pubmed:publicationType | Journal Article | lld:pubmed |
